WallStreetZenWallStreetZen

NYSE: ACA
Arcosa Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ACA past earnings growth

How has ACA's earnings growth performed historically?
Company
-35.63%
Industry
21.17%
Market
99.73%
ACA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ACA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ACA's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ACA past revenue growth

How has ACA's revenue growth performed historically?
Company
2.9%
Industry
15.46%
Market
17.8%
ACA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ACA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ACA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ACA earnings and revenue history

Current Revenue
$2.3B
Current Earnings
$159.2M
Current Profit Margin
6.9%

ACA Return on Equity

Current Company
6.9%
Current Industry
11.6%
Current Market
188%
ACA's Return on Equity (6.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ACA announces earnings.

ACA Return on Assets

Current Company
4.6%
Current Industry
4.9%
ACA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ACA Return on Capital Employed

Current Company
7.12%
Current Industry
12.1%
ACA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ACA vs Engineering & Construction Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ACA$2.31B$383.50M$159.20M+9.58%+16.10%
DY$4.18B$542.88M$218.92M+5.95%+29.99%
STRL$1.97B$273.15M$138.66M+13.71%+36.84%
EXPO$536.77M$144.81M$100.34M+7.18%+7.43%
MYRG$3.65B$187.42M$86.77M+17.14%+21.01%
View Top Engineering & Construction Stocks

ACA earnings dates

Next earnings date
May 8, 2024

Arcosa Earnings & Revenue FAQ

What were ACA's earnings last quarter?

On Invalid Date, Arcosa (NYSE: ACA) reported Q4 2023 earnings per share (EPS) of $0.56, up 82.5% year over year. Total Arcosa earnings for the quarter were $27.10 million. In the same quarter last year, Arcosa's earnings per share (EPS) was $3.20.

If you're new to stock investing, here's how to buy Arcosa stock.

What was ACA's earnings growth in the past year?

As of Q2 2024, Arcosa's earnings has grown -35.63% year over year. This is 56.8 percentage points lower than the US Engineering & Construction industry earnings growth rate of 21.17%. Arcosa's earnings in the past year totalled $159.20 million.

What is ACA's earnings date?

Arcosa's earnings date is Invalid Date. Add ACA to your watchlist to be reminded of ACA's next earnings announcement.

What was ACA's revenue last quarter?

On Invalid Date, Arcosa (NYSE: ACA) reported Q4 2023 revenue of $582.20 million up 16.37% year over year. In the same quarter last year, Arcosa's revenue was $500.30 million.

What was ACA's revenue growth in the past year?

As of Q2 2024, Arcosa's revenue has grown 2.9% year over year. This is 12.55 percentage points lower than the US Engineering & Construction industry revenue growth rate of 15.46%. Arcosa's revenue in the past year totalled $2.31 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.